Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HROW | Common Stock | Options Exercise | +347K | +106.94% | 671K | Jul 18, 2023 | Direct | F1 | ||
transaction | HROW | Common Stock | Tax liability | -$2.49M | -136K | -20.33% | $18.23 | 534K | Jul 18, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HROW | Performance Stock Unit | Options Exercise | $0 | -347K | -100% | $0.00* | 0 | Jul 18, 2023 | Common Stock | 347K | Direct | F1 |
Id | Content |
---|---|
F1 | The 346,500 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Boll under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 136,350 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Boll in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 346,500 shares pursuant to the terms of the Incentive Plan. |